Tadalafil zeigt eine konstante Resorption im Gastrointestinaltrakt, mit maximalen Plasmaspiegeln nach rund zwei Stunden. Der Wirkstoff verteilt sich gut im Gewebe und weist eine hohe Plasmaproteinbindung auf. Seine lange Halbwertszeit erlaubt eine verlängerte Wirkphase. Der Metabolismus erfolgt über das hepatische Enzymsystem CYP3A4, mit der Bildung inaktiver Metaboliten. Exkretion geschieht primär über den Stuhl. Die Häufigkeit von Nebenwirkungen steigt mit der Dosis, wobei vor allem vasodilatatorische Effekte dominieren. Ein gängiger Bezugspunkt in pharmakologischen Analysen ist cialis ohne rezept, das mit dieser Wirkstoffklasse assoziiert ist.
C:\ncs-vp8\221-3-inhalt.vp
Zeitschrift für Kristallographie New Crystal Structures Volume 221 · Issue 3 · 2006 Inorganic Crystal Structures S. Stoyko, S. Oryshchyn, V. Babizhetskyy and R. Guérin
Crystal structure of yttrium nickel phosphide,
J.-P. Wang, P.-T. Ma and J.-Y. Niu
Y20Ni42P30.34 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 259
Re-investigation of the crystal structure of dodecasodium
O. Sichevych, R. Cardoso-Gil and Yu. Grin
Na12[Mn(Nb6O19)2] · 52H2O . . . . . . . . . . . . . . . . . . . . . . . . 235
Refinement of the crystal structure of europium digallide,
EuGa2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 261
S. Budnyk, Yu. Prots, Yu. B. Kuz’ma and Yu. Grin
Crystal structures of trigadolinium tetraphosphidohepta-
O. Sichevych, Yu. Prots, W. Schnelle, M. Schmidt and
3Pd7P4, and triterbium tetraphosphidohepta-
Crystal structure of dieuropium trigallium iridium,
3Pd7P4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 238
Eu2Ga3Ir . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 263
A. Jiménez, J. D. Rodríguez, L. Torre-Fernández,M. Prieto and S. García-GrandaO. Sichevych, Yu. Prots and Yu. Grin
Crystal structure of dicalcium sodium monohydrogen
Re-investigation of the crystal structure of trieuropium
octagallide, Eu3–xGa8+3x (x = 0.12) . . . . . . . . . . . . . . . . . . . 265
E. Dashjav, W. Schnelle, F. R. Wagner, G. Kreiner and
Crystal structure of bismuth triiodate dihydrate,
Crystal structure of praseodymium dimolybdenum
Bi[IO3]3 · 2H2O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 243
disilicide carbide, PrMo2Si2C . . . . . . . . . . . . . . . . . . . . . . . 267
D. Grüner, A. Ormeci and G. Kreiner
Crystal structure of ytterbium triiodate dihydrate,
Crystal structure of niobium chromium nickel,
Yb[IO3]3 · 2H2O. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 245
Nb(Cr1–xNix)2 (x = 0.49)
. . . . . . . . . . . . . . . . . . . . . . . . . 269
Crystal structure of indium triiodate dihydrate,
Crystal structure of distrontium oxide diiodide, Sr2OI2. . . . 271
In[IO3]3 · 2H2O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 247
Organic and Metalorganic Crystal Structures
Crystal structure of indium triiodate trihydrate,
In[IO3]3 · 3H2O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 249
D.-Y. Wei, S.-J. Huang, J. Sun and Y.-Q. Zheng
Crystal structure of diaquadidysprosium triglutarate
P. W. Menezes, S. Hoffmann, Yu. Prots and R. Kniep
tetrahydrate, Dy2(H2O)2[O2C(CH2)3CO2]3 · 4H2O . . . . . . . 273
I. Warad, S. Al-Resayes and K. Eichele
Crystal structure of trans-dichloro-1,3-propanediamine-
2O8(OH)]. . . . . . . . . . . . . . . . . . . 251
bis[(2-methoxyethyl)diphenylphosphine]ruthenium(II),
P. W. Menezes, S. Hoffmann, Yu. Prots and R. Kniep
RuCl2(C3H10N2)(C15H17OP)2 . . . . . . . . . . . . . . . . . . . . . . . 275
S. Sörgel, I. Brüdgam, H. Hartl and H.-U. Reißig
Crystal structure of 2-bromo-1,4,5,7,8-pentamethoxy-
monophosphate), RbSc[BP2O8(OH)]. . . . . . . . . . . . . . . . . . 253
naphthalene, C10H2Br(OCH3)5 . . . . . . . . . . . . . . . . . . . . . . 278
A. Leithe-Jasper, R. Cardoso-Gil, R. Ramlau andL. Yang, W. Yu, T. Wu, T.-L. Zhang, J.-G. Zhang,
Crystal structure of tetraytterbium septarhodium
Crystal structure of carbohydrazidium(1+) p-toluene-
hexaantimony, Yb4Rh7Sb6 . . . . . . . . . . . . . . . . . . . . . . . . . . 255
sulfonate, (NH2NHCONHNH3)[CH3C6H4SO3] . . . . . . . . . 281
F. Haarmann, Yu. Prots, S. Göbel and H. G. von
Crystal structure of (2,6-diisopropyl-phenyl)[N-
Crystal structure of tristrontium octagallide,
tris(pentafluorophenyl)-boronyl-pyridin-2-yl]amine,
Sr3–xGa8+3x (x = 0.15). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 257
(C6F5)3B(C5H4N)(C12H18N) . . . . . . . . . . . . . . . . . . . . . . . . 283
Crystal structure of (1,8-diethyl-1,3,4,9-tetra-
Crystal structure of tetrakis(melaminium) 1,2,4,5-
hydropyrano[3,4-b]indol-1-yl)acetic acid
(2-hydroxy-benzylidene)hydrazide, C24H27N3O3 . . . . . . . . 285
(C3H7N6)4[C6H2(COO)4] · 8H2O. . . . . . . . . . . . . . . . . . . . . 313
Q. Deng, W.-J. Jiang, Z.-S. Peng, Y.-F. Long and T.-J. CaiY.-H. Deng, Y.-L. Yang and X.-J. Yang
Crystal structure of aquabis(acrylato-O,O¢)-
Crystal structure of diiodo-bis[(4R,5R)-trans-4,5-
(1,10-phenanthroline-N,N¢)zinc(II) hydrate,
bis[(diphenylphosphinomethyl)-2,2-dimethyl-1,3-
Zn(C3H3O2)2(H2O)(C12H10N2) · H2O . . . . . . . . . . . . . . . . . 287
dioxalane]dicopper(I), Cu2I2(C31H32O2P2)2 . . . . . . . . . . . . 316
R. D. Ernst, R. Basta and A. M. ArifL. Yu, P.-T. Ma, J. Li and J.-P. Wang
Refinement of the crystal structure of bis(2-hydroxy-
cyclohexadienyl)vanadium, V(C8H11)2 . . . . . . . . . . . . . . . . 289
1,10-phenanthroline)dicopper(I), Cu2(C12H7N2O)2. . . . . . . 319
R. D. Ernst, B. G. Harvey and A. M. Arif
Crystal structure of (hydrido)(h3-butenyl)-
bis(h5-pentamethylcyclopentadienyl)zirconium,
trimethylspiro[2H-1-benzopyran-2,2¢-indoline],
4H7)[C5(CH3)5]2(H) . . . . . . . . . . . . . . . . . . . . . . . . . . . 291
C19H17BrClNO. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 321
R. D. Ernst, V. Kulsomphob and A. M. Arif
Crystal structure of (h5-2,4-dimethylpentadienyl)[h2-rel-
M.-H. Wu, X.-H. Yang, W.-D. Zou, W.-J. Liu and C. Li
(aR)-a-[[(1R,5E)-5-[(1,1-dimethylethyl)imino]-1,3-
Refinement of the crystal structure of (E)-1,3-
dimethyl-2-cyclopenten-1-yl]methyl]-N-(1-methylethyl)-
diphenyl-2-propen-1-one, C15H12O . . . . . . . . . . . . . . . . . . . 323
benzenemethanaminato-kN][2-(isocyano-kC)-2-methyl-
Crystal structure of bis(cyclopropyl-4-bromosalicyl-
aldiminato)cobalt(II), Co(C20H18BrNO)2 . . . . . . . . . . . . . . 325
Crystal structure of bis(N-(2-aminoethyl)salicyl-
Y.-H. Luo, X.-J. Hu, J.-K. Liu, H. Zhang, Y. Li,
[Fe(C9H11N2O)2][NCS] . . . . . . . . . . . . . . . . . . . . . . . . . . . . 296
H.-J. Yang and R.-J. WangCrystal structure of 5,11,17,23-tetrabromo-25,27-
M.-Q. Cheng, L.-F. Ma and L.-Y. Wang
Crystal structure of catena-[(1,10-phenanthroline-N,N¢)-
C30H24Br4O4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 327
bis(m-acetato-O,O¢)lead(II)], Pb(C12H8N2)(CH3COO)2 . . . 299
X.-J. Hu, H.-J. Yang, J.-K. Liu, H. Zhang, Y. Li,G. Steiner, K. Wurst, B. Bildstein and H. KopackaY.-H. Luo, Y.-H. Luo and R.-J. Wang
Crystal structure of dichlorobis[N-(2,6-diisopropyl-
Crystal structure of 5,17-bis(N-tert-butylhydroxy-
phenyl)benzimidimidazolide]palladium(II),
amine)-25,26,27,28-tetrapropoxycalix[4]arene,
PdCl2(C22H25N3)2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 301
C48H66N2O6 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 329
G. Steiner, K. Wurst, B. Bildstein and H. KopackaQ.-H. Jin, J.-C. Dong, H.-W. Gao, X.-L. Xin, L. Yang
Crystal structure of dichloro(3-cyclopentadienyl-
3-methyl-1-phenyl-butyliden-2,6-dimethylphenyl-
Crystal structure of catena-poly[(m-2-aminopyrimidine-
amino)chromium(III), CrCl2(C24H26N) . . . . . . . . . . . . . . . . 303
N,N¢)bis(m-chloro)bis(triphenylphosphine)dicopper(I)],
M. Zareef, R. Iqbal, G. Qadeer, W.-Y. Wong, H. Akhtar
2Cl2[P(C6H5)3]2(C4H5N3) . . . . . . . . . . . . . . . . . . . . . . . . 332
Z.-S. Peng, W.-J. Jiang, Q. Deng, Y.-F. Long and T.-J. Cai
Crystal structure of 2-bromobenzoic acid hydrazide,
Refinement of the crystal structure of catena-[(1,10-
C7H7BrN2O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 305
phenanthroline-N,N¢)-(m3-molybdato(VI))copper(II)]
M. Zareef, R. Iqbal, J. H. Zaidi, G. Qadeer, W.-Y. Wong
monohydrate, Cu(C2H10N2)(MoO4) · H2O . . . . . . . . . . . . . 335
Crystal structure of picolinic acid hydrazide, C
D. B. Werz, S. Balalaie, F. Rominger and Z. Oloumi
Crystal structure of 2-(2-propynyloxy)benzaldehyde,
P. Lemoine, A. Bekaert, J. D. Brion and B. Viossat
C10H8O2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 337
Crystal structure of hexakis(m2-acetato)tris(acetonitrile-
D. B. Werz, S. Balalaie, F. Rominger and Z. Oloumi
3-oxo-trialuminum(III) tetrachloroaluminate,
Crystal structure of 2-[6-(2-formylphenoxy)-2,4-
3(C2H3O2)6(C2H3N)3O][AlCl4] . . . . . . . . . . . . . . . . . . . 309
hexadiynyloxy]benzaldehyde, C20H14O4 . . . . . . . . . . . . . . . 339
J. Zukerman-Schpector, R. Oliveira da Silva, P. R. Olivato,E. Vinhato, A. Rodrigues and C. R. Cerqueira Jr.
Crystal structure of 2-phenylsulfinyl-cyclohexanone,
Crystal structure of 2¢-hydroxyacetophenone nicotinoyl-
C12H14O2S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 311
hydrazone monohydrate, C14H15N3O3 · H2O. . . . . . . . . . . . 341
J.-N. Feng, Y.-Z. Zhou, H.-J. Zhu and S.-J. Tu
Crystal structure of ethanolammonium dioxo-(N-(2-
Crystal structure of tetraaqua-bis(norfloxacin)barium(II)
ethanolato)-2-oxy-3-methoxybenzaldiminato-O,N,O¢)-
[Ba(H2O)4(C16H17FN3O3)2][C6H4(COO)2] · H2O. . . . . . . . 372
(NH3CH2CH2OH)[VO2{(C6H4(OCH3)(O)CHNCCH2CH2O}]. . . 343
W.-D. Wang, H. Wang, W.-J. Feng, Z.-M. Jin and M.-L. HuG. N. Kaluderovic, G. A. Bogdanovic and T. J. Sabo
Crystal structure of caffeinium perchlorate monohydrate,
Crystal structure of ethylenediammonium-N,N¢-
(C8H11N4O2)[ClO4] · H2O . . . . . . . . . . . . . . . . . . . . . . . . . . 375
di-3-propionic acid tetrachloroplatinate(II),(CH2NH2(CH2)2COOH)2[PtCl4] . . . . . . . . . . . . . . . . . . . . . 345
Crystal structure of (acetonitrile-N)copper(I) cyanide,
[Cu(CH3CN)][CN] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 377
Crystal structure of rel-(3aR,4S,6aS)-4-chloromethyl-6-methyl-3,6a-diphenyl-3a,4,6,6a-tetrahydro-isoxazolo-
Crystal structure of dicyano(N-(1-iminoethyl)-
18H17ClN2O2 . . . . . . . . . . . . . . . . . . . . . 347
acetamidine)palladium(II), Pd(CN)2(C4H9N3). . . . . . . . . . . 379
W. Frey, S. Shiva and V. JägerCrystal structure of rel-(3aR,6aS)-6-methyl-3,6a-di-
G. Le Bras, A. Bekaert, B. Viossat, J.-F. Peyrat, M. Alami,
phenyl-3a,4,6,6a-tetrahydro-isoxazolo[5,4-c]isoxazole,
17H16N2O2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 349
H.-M. Guo, B.-S. Zhang and Y.-H. WangQ.-H. Jin, L. Yang, X.-L. Xin, H.-W. Gao, J.-C. Dong and
Crystal structure of bis(1,10-phenanthroline-N,N¢)bis(2-
Crystal structure of aqua(phenanthroline-N,N¢)-
(glycinato-N,O)copper(II) bromide hydrate,
7H4O2Cl)2(C12H8N2)2] · 2.5H2O . . . . . . . . . . . . . . . . 352
[Cu(NH2CH2COO)(C12H8N2)(H2O)]Br · H2O . . . . . . . . . . 383
B.-S. ZhangCrystal structure of (2,2¢-bipyridine-N,N¢)bis(2-
aquabis(2,2¢-bipyridine)bis(terephtalato)dicopper(II),
C. A. De Simone, V. L. M. Guarda, S. L. Galdino and
Cu2(H2O)(C10H8N2)2(C8H4O4)2 . . . . . . . . . . . . . . . . . . . . . 385
Crystal structure of 4-butyl-6-nitro-2H-1,4-benzothiazin-
Crystal structure of bis[(1,3-bis(4-pyridinium)-
3-one, C12H14N2O3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 357
propane)][ß-hexacosaoxooctamolybdate(VI)],
C. R. Doyle, M. D. Zimmerman, M. Chruszcz,
13H16N2)2[Mo8O26] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 388
M. Cymborowski, A. Gawlicka-Chruszcz and W. MinorP.-G. Li, Q.-L. Wang, D.-S. Li, F. Fu and G.-C. Qi
Crystal structure of 6-(4-difluoromethoxy-3-methoxy-
Crystal structure of bis(1,10-phenanthroline-N,N¢)silver(I)
phenyl)-3(2H)-pyridazinone, C12H10F2N2O3. . . . . . . . . . . . 359
mononitrate, [Ag(C12H8N2)2][NO3]. . . . . . . . . . . . . . . . . . . 391
S. Guo, R. Hauptmann, C. Beyer, T. Kollmann and
Refinement of the crystal structure of sinoacutine,
C19H21NO4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 361
Crystal structure of pentamethylpyrylium triiodide,
[(CH3)5C5O][I3] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 393
I.-C. Hwang and K. HaCrystal structure of aquachloro[N,N¢-bis(3-ethoxy-
F.-Q. Cao, Y. Wang, N. Okabe and M. Odoko
salicylidene)ethylenediiminato]manganese(III) dihydrate,
Crystal structure of aquabis(4-aminobenzoato)cadmium
[Mn(C20H22N2O4)Cl(H2O)] · 2H2O . . . . . . . . . . . . . . . . . . 363
dihydrate, Cd(H2O)(NH2C6H4COO)2 · 2H2O . . . . . . . . . . . 395
S. Florio, V. Capriati, R. Luisi, A. Salomone and C. Cuocci
Crystal structure of aquachloro[N,N¢-bis(3-ethoxy-
Crystal structure of (N-tert-butyl-3,4-diphenyl-1,2-
salicylidene)propylenediiminato]manganese(III) dihydrate,
oxazetidin-4-yl)methanol, C19H23NO2. . . . . . . . . . . . . . . . . 398
[Mn(C21H24N2O4)Cl(H2O)] · 2H2O . . . . . . . . . . . . . . . . . . 365
Y. B. Lee, T. H. Kim, I.-C. Hwang and K. Ha
Crystal structure of tetra(2-aminopyrimidine)di-
Crystal structure of N-benzoyl-4,4-dimethyl-2-methyl-
amino-2-thiazoline, C13H16N2OS. . . . . . . . . . . . . . . . . . . . . 367
[Co2(CH3O)2(C4H5N3)4][ClO4]2 . . . . . . . . . . . . . . . . . . . . . 401
M.-Q. Cheng, L.-F. Ma and L.-Y. Wang
Crystal structure of (phenanthroline-N,N¢)-N-carbamoyl-
Crystal structure of tetra(2-aminopyrimidine)di-
methyliminodiacetato-copper(II) dihydrate,
methanolato-dinickel(II) di(tetrafluoroborate),
[Cu(C6H8N2)(C12H8N2)] · 2H2O . . . . . . . . . . . . . . . . . . . . . 369
[Ni2(CH3O)2(C4H5N3)4][BF4]2 . . . . . . . . . . . . . . . . . . . . . . 403
T.-J. Cai, W.-J. Jiang, Z.-S. Peng, Y.-F. Long and Q. Deng
Crystal structure of bis(1,3-diaminepropane)carbonato-
Crystal structure of aquabis(acrylato-O,O¢)(1,10-
phenanthroline-N,N¢)cadmium(II),
[Mn(C3H10N2)2(CO3)]Cl · H2O . . . . . . . . . . . . . . . . . . . . . . 405
Cd(H2O)(C3H3O2)2(C12H10N2) . . . . . . . . . . . . . . . . . . . . . . 421
Crystal structure of m-terephthalatobis[bis(1,3-diamino-
Crystal structure of dichloro-bis(n-pentyl)tin(IV),
Sn(C5H11)2Cl2, tin-halide compounds – part VI . . . . . . . . . 423
[Mn2{C3H6(NH2)2}4{C6H4(COO)2}][ClO4]2 . . . . . . . . . . . 407
S.-P. Xu, C.-H. Liu and S.-F. Wang
Crystal structure of acetato-m-N,N¢-bis(salicylidene)-
3-methyl-3-aza-1,5-pentanediaminocobalt(III),
Co(C2H3O2)(C21H25N3O2). . . . . . . . . . . . . . . . . . . . . . . . . . 409
H. Maisel, G. Glatz, T. Irrgang and R. Kempe
Crystal structure of dicyclohexyl-2,2¢-dipyridylamido-
Instructions to Contributors
phosphane, C22H30N3P. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 411
T. Irrgang, A. Spannenberg and R. Kempe
Crystal structure of bis(1,3-bis[{4-methyl-pyridin-2-yl}-
amido]-1,1,3,3-tetramethyldisiloxane)dichromium
dichloride, [(C16H24N4OSi2)CrCl]2 . . . . . . . . . . . . . . . . . . . 413
Further details of the structure determination can be accessed at
Crystal structure of tetrakis[(4-methyl-pyridin-2-yl)tri-
Data with CSD numbers can be obtained from the Fachinforma-
methylsilanyl-amido]zirconium(IV), Zr(C9H15N2Si)4. . . . . 415
tionszentrum Karlsruhe, Gesellschaft für wissenschaftlich-tech-
nische Information mbH, D-76344 Eggenstein-Leopoldshafen,
Z. García-Hernández, B. Wrackmeyer, M. Herberhold,
Germany (e-mail: docdel@fiz-karlsruhe.de).
Data with CCDC numbers can be obtained from the Cambridge
Crystal structure of 3,4,7,8-bis(1,2-dicarba-closo-
Crystallographic Data Centre (CCDC), 12 Union Road,
dodecaborano[1,2])-1,2,5,6-tetraselenacyclooctane
Cambridge CB2 1EZ, UK, (fax: +44-(0)1223-33 60 33 or e-mail:
benzene solvate, [(C2B10H10)Se2]2 · C6D6 . . . . . . . . . . . . . . 419
REDAZIONALE Eccoci qui al ritorno dallo Zoomark a tirare un po' le somme. Ho sempre detto e purtroppo continuo a ripeterlo anche in questaoccasione, che i nostri soci sono sempre un po' troppo pigri, mostrano poca volontá di partecipare alle attivitá organizzate L'ultima assemblea é andata praticamente deserta. La cena sociale del 20 aprile é saltata per . scarsa partecipazione. La gi
A recent jury trial verdict may have created supply issues for the generic fixed-dosed combination of trandolapril/verapamil hydrochloride ER. In order to help prevent disruption in therapy, Abbott wants to make you aware that their branded TARKA (trandolapril/verapamil hydrochloride ER) is available with no supply issues in all four dosage strengths. How this change affects patients